Retrophin Inc (NASDAQ:RTRX) Files An 8-K

Alvin Shih, M.D. resigned as Executive Vice President of Research and Development of Retrophin Inc (NASDAQ:RTRX), effective as of October 31, 2016. Following the effectiveness of his resignation, Dr. Shih has agreed to serve as a consultant to the Company. The Company has initiated a search for a permanent successor to Dr. Shih. In the interim, Stephen Aselage, the Company’s Chief Executive Officer, will assume responsibility of the Company’s research and development organization.

An ad to help with our costs